The U.S. Supreme Court decided Thursday to preserve telehealth access to the abortion drug mifepristone until after the U.S. 5th Circuit Court of Appeals has ruled on the merits of the high-stakes federal lawsuit Louisiana v. Food and Drug Administration. Justices Samuel Alito and Clarence Thomas issued dissenting opinions. In his dissent, Thomas said the […]
Full article not available — click below to read at the source.
Comments
No comments yet. Be the first.
Sign in to leave a comment.